How does anastrozole work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Anastrozole Works

Anastrozole is a selective, non-steroidal aromatase inhibitor that blocks the conversion of adrenal androgens (primarily androstenedione and testosterone) to estrogens (estrone and estradiol) in peripheral tissues, thereby suppressing estrogen biosynthesis in postmenopausal women. 1

Mechanism of Action

Anastrozole works by specifically inhibiting the aromatase enzyme, which is the key enzyme responsible for estrogen production in postmenopausal women. Since many breast cancers are stimulated or maintained by estrogens, blocking this enzyme effectively starves hormone-dependent tumors of their growth stimulus 1.

Pharmacologic Effects

  • Estrogen Suppression: Anastrozole 1 mg daily reduces serum estradiol by approximately 70% within 24 hours and by approximately 80% after 14 days of treatment, lowering estradiol to the lower limit of detection (3.7 pmol/L) 1
  • Selectivity: The drug has no detectable effect on formation of adrenal corticosteroids, aldosterone, thyroid function, or other steroid hormones, making it highly selective for aromatase 1
  • Duration of Effect: Suppression of serum estradiol is maintained for up to 6 days after stopping the medication 1

Clinical Context

Anastrozole only works in postmenopausal women because aromatization of adrenal androgens is not a significant source of estradiol in premenopausal women 2. In premenopausal women, the ovaries are the primary source of estrogen, so anastrozole would not be expected to lower estradiol levels effectively 1.

Approved Uses

The drug is used for:

  • Breast cancer risk reduction in high-risk postmenopausal women (1 mg daily for 5 years) 2
  • Treatment of hormone receptor-positive breast cancer in postmenopausal women 1

The IBIS-II trial demonstrated that anastrozole reduces the risk of estrogen receptor-positive breast cancers by approximately 58% (HR 0.42; 95% CI, 0.25-0.71) in postmenopausal women at increased risk 2.

Important Clinical Considerations

Key side effects relate directly to estrogen suppression: bone loss and increased fracture risk, musculoskeletal symptoms (joint stiffness, arthralgia), vasomotor symptoms (hot flashes), and cardiovascular considerations 2. These effects occur because estrogen plays protective roles in bone metabolism and cardiovascular health that are lost when the drug blocks estrogen production.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.